X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
urology (154) 154
humans (152) 152
male (143) 143
index medicus (134) 134
aged (130) 130
urology & nephrology (130) 130
middle aged (123) 123
cancer (100) 100
aged, 80 and over (97) 97
adult (91) 91
prostate cancer (80) 80
female (68) 68
surgery (56) 56
mortality (51) 51
health aspects (49) 49
prognosis (49) 49
neoplasm staging (47) 47
survival (47) 47
analysis (42) 42
care and treatment (42) 42
radical prostatectomy (41) 41
kidney neoplasms - surgery (39) 39
oncology (39) 39
prostatic neoplasms - surgery (38) 38
prostatectomy (36) 36
prostatic neoplasms - pathology (36) 36
treatment outcome (36) 36
outcomes (35) 35
nephrectomy (33) 33
carcinoma (32) 32
abridged index medicus (31) 31
patient outcomes (31) 31
kidney neoplasms - pathology (30) 30
research (30) 30
retrospective studies (30) 30
carcinoma, renal cell (29) 29
nomogram (29) 29
seer program (29) 29
carcinoma, renal cell - surgery (28) 28
kidney neoplasms - mortality (28) 28
men (28) 28
cohort studies (27) 27
risk factors (27) 27
comorbidity (26) 26
life sciences (25) 25
nephrectomy - methods (23) 23
tumors (23) 23
human health and pathology (22) 22
young adult (22) 22
impact (21) 21
united states - epidemiology (21) 21
urinary bladder neoplasms - surgery (21) 21
urology and nephrology (21) 21
carcinoma, renal cell - mortality (20) 20
diagnosis (20) 20
metastasis (20) 20
survival analysis (20) 20
[sdv.mhep.un]life sciences [q-bio]/human health and pathology/urology and nephrology (19) 19
carcinoma, renal cell - pathology (19) 19
risk (19) 19
time factors (19) 19
[sdv.can]life sciences [q-bio]/cancer (18) 18
complications (18) 18
lymphatic metastasis (18) 18
prostatectomy - methods (18) 18
radical cystectomy (18) 18
recurrence (18) 18
survival rate (18) 18
adolescent (17) 17
bladder cancer (17) 17
cystectomy (17) 17
multivariate analysis (17) 17
nomograms (17) 17
oncology, experimental (17) 17
predictive value of tests (17) 17
united states (17) 17
united-states (17) 17
validation (17) 17
epidemiologic methods (16) 16
kidney neoplasms (16) 16
prostatic neoplasms (16) 16
prostatic neoplasms - mortality (16) 16
radiotherapy (16) 16
risk assessment (16) 16
management (15) 15
morbidity (15) 15
prostate (15) 15
renal cell carcinoma (15) 15
urinary bladder neoplasms - pathology (15) 15
biopsy (14) 14
mesh: humans (14) 14
therapy (14) 14
urinary bladder neoplasms - mortality (14) 14
mesh: middle aged (13) 13
prostate - pathology (13) 13
regression analysis (13) 13
carcinoma, transitional cell - surgery (12) 12
follow-up studies (12) 12
hematology, oncology and palliative medicine (12) 12
lymphadenectomy (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2007, Volume 53, Issue 5, pp. 917 - 930
Abstract Objective To provide a systematic review of the side effects associated with sorafenib, sunitinib, and temsirolimus and to provide an outline of... 
Urology | Temsirolimus | Side effects | Sunitinib | Sorafenib | sunitinib | MAMMALIAN TARGET | BAY-43-9006 | sorafenib | DAYS ON/7 DAYS | RAF KINASE | TYROSINE KINASE INHIBITORS | GROWTH-FACTOR RECEPTOR | INTERFERON-ALPHA | temsirolimus | PHARMACOKINETICS | UROLOGY & NEPHROLOGY | side effects | REFRACTORY SOLID TUMORS | PHASE-I | Niacinamide - analogs & derivatives | Receptors, Vascular Endothelial Growth Factor | Drug-Related Side Effects and Adverse Reactions - prevention & control | Prognosis | Humans | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Benzenesulfonates - administration & dosage | Indoles - administration & dosage | Benzenesulfonates - adverse effects | Dose-Response Relationship, Drug | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Pyrroles - administration & dosage | Pyrroles - adverse effects | Carcinoma, Renal Cell - drug therapy | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Pyridines - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Sirolimus - administration & dosage | Indoles - adverse effects | Carcinoma, Renal Cell - secondary | Kidney Neoplasms - pathology | Kidney Neoplasms - drug therapy | Drug-Related Side Effects and Adverse Reactions - diagnosis | Metastasis | Life Sciences | Pharmaceutical sciences | Cancer
Journal Article
European Urology, ISSN 0302-2838, 2007, Volume 54, Issue 6, pp. 1306 - 1313
Abstract Objectives The Epstein criteria represent the most widely used scheme for prediction of clinically insignificant prostate cancer (PCa). However, they... 
Urology | Epstein criteria | Prediction | Insignificant prostate cancer | INTERNAL VALIDATION | PATHOLOGICAL STAGE | RADICAL PROSTATECTOMY | EXTERNAL VALIDATION | CLINICAL STAGE | GLEASON SUM | UROLOGY & NEPHROLOGY | NEEDLE-BIOPSY | NOMOGRAM | PROGRESSION | Prostatic Neoplasms - pathology | Europe | Humans | Middle Aged | Adult | Male | Aged | Prostate cancer | Analysis
Journal Article
Journal Article
The Journal of Urology, ISSN 0022-5347, 04/2007, Volume 177, Issue 4, pp. 126 - 126
Journal Article
The Journal of Urology, ISSN 0022-5347, 04/2007, Volume 177, Issue 4, pp. 129 - 129
Journal Article
The Journal of Urology, ISSN 0022-5347, 04/2007, Volume 177, Issue 4, pp. 493 - 493
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.